Literature DB >> 12466266

Regulation of estrogen receptor alpha-mediated transcription by a direct interaction with protein phosphatase 2A.

Qing Lu1, Howard K Surks, Heather Ebling, Wendy E Baur, Donald Brown, David C Pallas, Richard H Karas.   

Abstract

Estrogen receptor alpha (ERalpha) mediates the effects of estrogen by altering gene expression following hormone binding. It has recently been shown that kinase-mediated phosphorylation of ERalpha also transcriptionally activates the receptor in the absence of estrogen. We now report that ERalpha-dependent gene expression also is regulated by protein phosphatase 2A (PP2A). ERalpha co-immunoprecipitates with enzymatically active PP2A. ERalpha binds directly to the catalytic subunit of PP2A, which dephosphorylates serine 118 of the receptor. Amino acids 176-182 in the A/B domain of ERalpha are required for the interaction between PP2A and the receptor. Phosphatase inhibition disrupts the ERalpha-PP2A complex and induces formation of an ERalpha-activated mitogen-activated protein kinase complex, phosphorylation of ERalpha on serine 118, and transcriptional activation. These findings demonstrate that estrogen receptors exist in complexes with phosphatases as well as kinases. We propose a new model of ligand-independent activation of estrogen receptors in which the level of phosphorylation of ERalpha, and hence its transcriptional activation, is determined by the net effect of these counterregulatory pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466266     DOI: 10.1074/jbc.M210949200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.

Authors:  Claudia Bocca; Francesca Bozzo; Andrea Bassignana; Antonella Miglietta
Journal:  Mol Cell Biochem       Date:  2010-12-08       Impact factor: 3.396

2.  Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection.

Authors:  Kun Don Yi; James W Simpkins
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

Review 3.  Non-nuclear estrogen receptor signaling in the endothelium.

Authors:  Qian Wu; Ken Chambliss; Michihisa Umetani; Chieko Mineo; Philip W Shaul
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

4.  Distribution and posttranslational modification of synaptic ERα in the adult female rat hippocampus.

Authors:  Nino Tabatadze; Tereza Smejkalova; Catherine S Woolley
Journal:  Endocrinology       Date:  2012-11-26       Impact factor: 4.736

5.  Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.

Authors:  P Rajbhandari; K A Schalper; N M Solodin; S J Ellison-Zelski; K Ping Lu; D L Rimm; E T Alarid
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

Review 6.  STRIPAK complexes: structure, biological function, and involvement in human diseases.

Authors:  Juyeon Hwang; David C Pallas
Journal:  Int J Biochem Cell Biol       Date:  2013-12-11       Impact factor: 5.085

7.  SPBP is a phosphoserine-specific repressor of estrogen receptor alpha.

Authors:  Valentina Gburcik; Nathalie Bot; Marcello Maggiolini; Didier Picard
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

8.  Heavy metal-induced metallothionein expression is regulated by specific protein phosphatase 2A complexes.

Authors:  Liping Chen; Lu Ma; Qing Bai; Xiaonian Zhu; Jinmiao Zhang; Qing Wei; Daochuan Li; Chen Gao; Jie Li; Zhengbao Zhang; Caixia Liu; Zhini He; Xiaowen Zeng; Aihua Zhang; Weidong Qu; Zhixiong Zhuang; Wen Chen; Yongmei Xiao
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

9.  Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover.

Authors:  Chao Li; Yao-Yun Liang; Xin-Hua Feng; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

10.  Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function.

Authors:  Katelee Barrett Mueller; Qing Lu; Najwa N Mohammad; Victor Luu; Amy McCurley; Gordon H Williams; Gail K Adler; Richard H Karas; Iris Z Jaffe
Journal:  Endocrinology       Date:  2014-07-22       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.